Neudolox (Pregabalin)

Pregabalin, the active ingredient in Neudolox, is a gabapentinoid presented as an oral tablet for oral use. It is indicated for neuropathic pain, partial seizures, generalized anxiety disorder, and fibromyalgia in adult patients. Its mechanism involves binding to the α2δ subunit of voltage‑gated calcium channels, reducing excitatory neurotransmitter release.

GNH USA supplies Neudolox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with manufacturing adhering to EU Good Manufacturing Practice and distribution to multiple regions.

Pregabalin is used in several neurological and pain‑related conditions, acting on the central nervous system to modulate abnormal neuronal activity.

- Neuropathic pain: Reduces pain intensity and improves functional outcomes in conditions such as diabetic peripheral neuropathy and post‑herpetic neuralgia. - Partial seizures (epilepsy): Decreases seizure frequency as adjunctive therapy in adults with focal onset seizures. - Generalized anxiety disorder: Alleviates anxiety symptoms and improves overall anxiety rating scales. - Fibromyalgia: Mitigates widespread musculoskeletal pain and associated fatigue in fibromyalgia patients.

Pregabalin may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dizziness - Somnolence - Peripheral edema - Weight gain - Blurred vision - Dry mouth

Serious or Rare Side Effects: - Angioedema or severe allergic reactions - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Suicidal thoughts or behavior - Respiratory depression, especially with CNS depressants - Hematologic abnormalities such as neutropenia - Severe skin rash or bullous eruptions

When prescribing Pregabalin, clinicians should observe several safety considerations.

- Assess renal function: Adjust dose in patients with impaired kidney function. - Monitor for suicidal ideation: Observe mood changes, especially during treatment initiation. - Avoid abrupt discontinuation: Taper the dose to reduce withdrawal symptoms. - Use caution in elderly: Increased sensitivity to CNS effects may occur. - Review concomitant CNS depressants: Combined use can enhance sedation and respiratory depression. - Store at room temperature: Keep in original container, protect from moisture and direct sunlight.

Pregabalin can interact with other medicines, requiring attention to potential additive effects.

Major Interactions (Avoid): - Opioids or strong CNS depressants: Combined use may cause profound sedation or respiratory depression. - Alcohol: Increases risk of dizziness, somnolence, and impaired coordination.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: May enhance hypotensive effect, requiring blood pressure monitoring. - Diuretics: Can increase risk of peripheral edema. - Certain antiepileptic drugs (e.g., carbamazepine): May alter pregabalin plasma levels.